| Meet ITM OncoBeta at the ACD 44th Annual Scientific Meeting in Perth, 15th - 18th of May, 2011 |
| Monday, 09 May 2011 17:31 | |
|
We are looking forward to meeting you at the 44th Annual Scientific Meeting of the Australasian College of Dermatologists "ACD" in the Riverside Theatre of the Perth Convention and Exhibition Centre (PCEC) in Western Australia from 15th to 18th of May 2011. One Highlight of this event is the skin cancer symposium on May 16th, 2011. Oliver Buck (CEO ITM AG and member of the Board of ITM OncoBeta GmbH) will give a talk about topical radiotherapy using Rhenium-188 (Rhenium-SCT) for SCC/BCC in the session from 1.30 pm to 3.00 pm.
We are looking forward to meeting you at the ACD Meeting
For further information please visit the website of the 44th Annual Scientific Meeting of the Australasian College of Dermatologists "ACD" or contact OncoBeta Australia Pty. Ltd., Dr. Michael Hauck (Managing Director). |
News
ITG has received the Manufacturing License for Lu-177 n.c.a.As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the...Read more... |
ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopesGarching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...Read more... |
Helmholtz Zentrum München and ITM AG enter antibody dealAscenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...Read more... |